Syndrom ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  12.0% 12.2% 7.6% 8.1% 7.0%  
Credit score (0-100)  21 19 30 29 33  
Credit rating  BB BB BB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  675 936 854 1,219 1,270  
EBITDA  114 383 243 511 577  
EBIT  37.7 224 131 351 440  
Pre-tax profit (PTP)  37.7 224.1 131.2 351.2 440.1  
Net earnings  29.4 174.8 102.3 273.9 343.3  
Pre-tax profit without non-rec. items  37.7 224 131 351 440  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  177 121 492 380 285  
Shareholders equity total  138 202 192 231 452  
Interest-bearing liabilities  109 71.8 328 566 623  
Balance sheet total (assets)  397 545 773 963 1,228  

Net Debt  -61.0 -130 106 13.4 -238  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  675 936 854 1,219 1,270  
Gross profit growth  -9.7% 38.5% -8.7% 42.8% 4.1%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  397 545 773 963 1,228  
Balance sheet change%  -13.3% 37.2% 41.9% 24.6% 27.5%  
Added value  114.1 382.9 243.1 463.1 576.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  101 -215 259 -271 -232  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  5.6% 24.0% 15.4% 28.8% 34.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  8.8% 47.6% 19.9% 40.5% 40.2%  
ROI %  18.4% 86.1% 33.1% 53.4% 47.0%  
ROE %  19.6% 102.7% 52.0% 129.8% 100.6%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  34.8% 37.1% 24.8% 23.9% 36.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -53.5% -34.1% 43.7% 2.6% -41.2%  
Gearing %  78.8% 35.5% 171.1% 245.3% 137.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.8 1.2 0.5 0.8 1.2  
Current Ratio  0.8 1.2 0.5 0.8 1.2  
Cash and cash equivalent  169.7 202.2 221.4 552.4 860.6  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -39.4 81.3 -300.5 -149.8 166.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0